News

Celebrating Excellence: Top Surgeons Recognized in Endocrine Care

Celebrating Excellence: Top Surgeons Recognized in Endocrine Care

Exceptional Recognition for Leading Surgeons in Endocrine Surgery

Dr. Jim Norman and Dr. Gary Clayman Acknowledged as Premier Specialists

The Hospital for Endocrine Surgery is proud to announce that two of its distinguished surgeons, Dr. Jim Norman and Dr. Gary Clayman, have been honored in the prestigious Castle Connolly Top Doctors list for 2025. This remarkable acknowledgment, awarded for the 12th consecutive year, reinforces their reputations as the foremost experts in parathyroid and thyroid surgery, respectively. This recognition contributes to the hospital's esteemed reputation as a global leader in endocrine surgery.

A Benchmark for Surgical Excellence

The Castle Connolly Top Doctors list symbolizes the top 7% of practicing physicians across the nation. These renowned doctors are peer-nominated and rigorously vetted by a physician-led research team, ensuring they are exemplars of clinical excellence, skill, and exceptional patient outcomes. Dr. Norman and Dr. Clayman's presence in this distinguished group speaks volumes about their unparalleled expertise and relentless commitment to advancing the field of endocrine surgery.

Dr. Jim Norman: The World's Leading Parathyroid Surgeon

Dr. Jim Norman, founder of the Norman Parathyroid Center, has gained widespread recognition as the best parathyroid surgeon globally. With a staggering number of over 3,500 parathyroid surgeries performed each year, he holds the record as the most experienced surgeon in this area. His inclusion in the Castle Connolly Top Doctors list for 2025 not only underscores his exceptional skill but also his dedication to transforming the lives of patients affected by hyperparathyroidism.

Hyperparathyroidism is a significant yet frequently underdiagnosed condition, often stemming from overactive parathyroid glands. This condition can lead to severe health issues, including osteoporosis, kidney stones, chronic fatigue, and cognitive decline. Dr. Norman has innovated the minimally invasive radio-guided parathyroidectomy (MIRP) procedure, which not only enhances recovery times but also minimizes scarring while improving patient outcomes. Patients from across the nation and around the world turn to Dr. Norman, confident in his expertise and the likelihood of a cure they can achieve together.

Dr. Norman emphasizes, "At the Norman Parathyroid Center, our mission is clear: to cure hyperparathyroidism. Our results reflect our commitment to improving patient lives and surgical outcomes, and this recognition from Castle Connolly reaffirms our efforts in this vital work."

Dr. Gary Clayman: Renowned Thyroid Surgeon

Dr. Gary Clayman, founder of the Clayman Thyroid Center, is consistently recognized as the country's top thyroid surgeon. Annually, he performs over 2,000 thyroid surgeries, establishing himself as a leader known for his exceptional skills in managing complex and advanced thyroid conditions. His unwavering dedication to surgical excellence and patient-centered care has earned him a respected position among the 2025 Castle Connolly Top Doctors.

With the rising rates of thyroid cancer, particularly among women, the necessity for expert surgical care has never been more evident. Dr. Clayman specializes in challenging thyroid surgeries, including total thyroidectomies and advanced cancer surgeries that may require neck dissections. Patients facing aggressive or recurrent thyroid cancer seek his expertise, as he offers them the best opportunity for recovery.

"Being recognized as the best thyroid surgeon is a tremendous honor, but more importantly, it reflects our entire team's dedication to ensuring our patients achieve the best possible outcomes," Dr. Clayman stated. He added, "Thyroid surgery requires a nuanced approach to suit each patient's needs and maximize their long-term health."

Hospital for Endocrine Surgery: A Leader in Endocrine Health

The Hospital for Endocrine Surgery is unique in its exclusive focus on thyroid, parathyroid, and adrenal surgery. It stands as the only institution of its kind globally and is home to the highest volume of endocrine surgeries performed by its expert surgeons, totaling over 5,000 procedures annually. Patients travel from all fifty states and over ninety nations to find the world's leading parathyroid, thyroid, and adrenal surgeons at this esteemed hospital.

The hospital's commitment to specialized, high-volume surgical care results in significantly improved cure rates, fewer complications, and expedited recoveries. Unlike many other hospitals, which offer endocrine surgeries sporadically, the Hospital for Endocrine Surgery provides tailored treatments exclusively for endocrine conditions, ensuring patients receive expert care that meets their specific needs.

The Importance of Choosing the Right Surgeon

When it comes to thyroid or parathyroid surgeries, selecting the right surgeon can be pivotal. The experience and abilities of the surgeon have direct implications on patient outcomes, complication risks, and overall health post-surgery. Patients searching for the premier parathyroid or thyroid surgeon should keep the following in mind:

  • Surgical Volume is Crucial: Surgeons who perform a high frequency of procedures yield better results.
  • Specialized Knowledge is Essential: The surgeons at the Hospital for Endocrine Surgery dedicate their practice solely to endocrine surgery, maintaining rigorous standards of precision and excellence.
  • A Tailored Approach Yields Better Outcomes: Both Dr. Norman and Dr. Clayman emphasize creating personalized treatment plans, increasing the likelihood of successful surgeries and quicker recoveries.

For individuals diagnosed with hyperparathyroidism, thyroid nodules, or thyroid cancer, seeking treatment from the world's preeminent parathyroid surgeon or thyroid surgeon can significantly influence recovery success.

A Commitment to Excellence in Endocrine Surgery

The Castle Connolly Top Doctors recognition bestowed upon Dr. Jim Norman and Dr. Gary Clayman is more than just an accolade; it represents the Hospital for Endocrine Surgery's commitment to providing the highest standards of endocrine care globally. As the hospital consistently achieves record-breaking surgical success and patient outcomes, its status as the foremost center for thyroid, parathyroid, and adrenal surgery remains unmatched.

About the Norman Parathyroid Center

Located in Tampa, Florida, the Norman Parathyroid Center is known for its excellence in treating parathyroid gland tumors and performs nearly 3,800 operations every year. With cure rates exceeding 99%, each operation typically lasts around 20 minutes, highlighting the center's efficiencies. Their success is attributed to a synergistic approach by the world's most knowledgeable and skilled parathyroid surgeons.

Contact Information:

(813) 972-0000

About the Clayman Thyroid Center

The Clayman Thyroid Center is recognized as the highest-volume thyroid cancer referral center across the nation. Founded by a leading thyroid surgeon, the Center offers individualized patient care that enhances the likelihood of a cure while also ensuring optimal wellness and aesthetic outcomes through various thyroid surgeries.

Contact Information:

(813) 940-3130

Frequently Asked Questions

What types of surgeries does the Hospital for Endocrine Surgery specialize in?

The Hospital for Endocrine Surgery focuses exclusively on thyroid, parathyroid, and adrenal surgeries.

Who are the renowned surgeons recognized by Castle Connolly?

Dr. Jim Norman and Dr. Gary Clayman have been recognized as leading specialists in parathyroid and thyroid surgeries.

How does surgical volume affect patient outcomes?

Surgeons with high procedure volumes tend to achieve better outcomes and lower complication rates.

Why is specialized expertise important in endocrine surgery?

Specialized surgeons focus solely on endocrine operations, ensuring optimal precision and care tailored to each patient's needs.

What commitment does the Hospital for Endocrine Surgery uphold?

The Hospital for Endocrine Surgery is committed to delivering the highest level of care and achieving exceptional patient outcomes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Euroandinos Paita Closes Consent for 2037 Notes

Updated Category News Views 122

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 104

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 81

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 120

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 106

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 138

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 244

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 95

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading

Top 5 Most Recently Viewed Articles

Under Armour and UNLESS: A New Era in Sustainable Sportswear

Updated Category News Views 185

Under Armour and UNLESS Unveil Groundbreaking Sportswear Innovative Launch at Milan Design Week Under Armour, Inc. and UNLESS, Inc. are set to revolutionize the sportswear industry by introducing a remarkable regenerative sportswear collection during Milan Design Week. This innovative project is a significant milestone representing their first collaboration, focusing on...

Continue Reading
Primech Holdings Expands Reach in North America, Targets Growth

Updated Category News Views 111

Primech Holdings Expands Presence in North America Primech Holdings Limited (NASDAQ: PMEC) has marked a significant milestone by opening its United States office in Edwardsville, Illinois. This expansion into North America is driven by the increasing demand for advanced, AI-driven cleaning solutions among institutional clients. Strategic Location for Growth Illinois was...

Continue Reading
Quantum Computing Inc. Secures $500 Million Through Private Placement

Updated Category News Views 296

Quantum Computing Inc. Strengthens Financial Backbone Quantum Computing Inc. (NASDAQ: QUBT), a pioneering company in the realm of integrated photonics and quantum optics technologies, has made headlines with its significant financing move. Recently, QCi announced that it has successfully arranged a private placement of common stock, amassing $500 million. This capital...

Continue Reading
Glaukos Takes Major Step with Epioxa™ FDA Application

Updated Category News Views 80

Glaukos Takes Major Step with Epioxa™ FDA Application Glaukos Corporation (NYSE: GKOS), a distinguished ophthalmic pharmaceutical and medical technology enterprise, has made significant strides by filing a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for Epioxa™, its state-of-the-art keratoconus therapy. This innovative treatment...

Continue Reading
Freshpet's Upcoming Q1 2025 Results and Company Growth Insights

Updated Category News Views 222

Freshpet to Share First Quarter Results for 2025 Freshpet, Inc. is set to disclose its financial results for the first quarter concluding on March 31, 2025. The announcement is scheduled for the morning of May 5, 2025, just before the market opens. As a public company operating under Nasdaq: FRPT, Freshpet has garnered significant attention in the pet food industry....

Continue Reading